ClinicalTrials.Veeva

Menu

Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Coronary Thrombosis

Treatments

Other: Blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT02591264
90-14-HYMC

Details and patient eligibility

About

The aim of this study is to determine the role of human neutrophil peptide-1 to 3 in the occurrence of periprocedural myocardial infarction.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Troponin negative patients
  • Stable angina
  • Unstable angina
  • Positive screening tests

Exclusion criteria

  • Troponin positive
  • Technical failure of procedure
  • Hemodynamic unstability

Trial contacts and locations

1

Loading...

Central trial contact

Rami Abu Fanne, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems